Home › Digestive Diseases › NCT02897908

Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Subjects with known, or suspected risk factors for steatosis (fat) or hepatic fibrosis
* Subjects who have been previously diagnosed with Non-Alcoholic Steatohepatitis (NASH) but who do not have current steatosis (fat) or fibrosis scoring
* Subjects who have other known liver diseases ie: HCV

Exclusion Criteria:

* Patients less than 18 years of age
* Pregnancy
* Patients that do not want to be contacted for consideration in future research studies.
* Patients diagnosed with ascites or peritoneal dialysis
* Body mass index (BMI) ≥40

About the study

The primary goal of this study is to establish a database of people with varying levels of hepatic fibrosis and various etiologies of liver disease for use in future research protocols.

What is being tested

• vibration controlled transient elastography (VCTE) (procedure)

Sponsor: State University of New York at Buffalo · Participants: 1,000 · Started: Oct 28, 2016

Contact the study team

• Ajay Chaudhuri, MD · Phone: 716-907-1916
• Andrew Talal, MD · Phone: 716-888-4737

Official record on ClinicalTrials.gov — NCT02897908

Locations in the U.S.

Conditions

• Digestive Diseases

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.